|
|
|
Insider
Information: |
Baker Brothers Life Sciences Lp |
Relationship: |
Director |
City: |
New York |
State: |
NY |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
15 |
|
Direct
Shares |
28,278,373 |
|
Indirect Shares
|
99,473,529 |
|
|
Direct
Value |
$957,670,069 |
|
|
Indirect Value
|
$2,829,148,386 |
|
|
Total
Shares |
127,751,902 |
|
|
Total
Value |
$3,786,818,455 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
13
|
1
|
Stock
price went up :
|
11
|
0
|
Stock
price went down : |
2
|
1
|
|
|
|
Gain/Loss Ratio : |
5.5
|
-1.0
|
Percentage
Gain/Loss : |
19.7%
|
-22.5%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Synageva BioPharma Corp |
GEVA |
Director |
2012-07-13 |
5,077,676 |
|
0 |
Premium* |
|
XOMA Corporation |
XOMA |
Director |
2012-07-19 |
13,606,093 |
|
0 |
Premium* |
|
Genomic Health Inc |
GHDX |
Director |
2012-07-26 |
9,086,690 |
|
0 |
Premium* |
|
Acadia Pharmaceuticals Inc |
ACAD |
Director, 10% Owner |
2023-06-01 |
205,752 |
2023-06-01 |
39,330,977 |
Premium* |
|
Seagen Inc |
SGEN |
Former 10% Owner, Dire... |
2023-12-14 |
0 |
2023-12-14 |
0 |
Premium* |
|
Incyte Corp |
INCY |
Director, 10% Owner |
2017-09-08 |
119,681 |
2017-09-08 |
822,826 |
Premium* |
|
Aceragen, Inc |
ACGN |
Director |
|
0 |
2014-03-10 |
1,613,076 |
Premium* |
|
Alexion Pharmaceuticals Inc |
ALXN |
Director |
2017-06-15 |
131,963 |
2017-06-15 |
1,074,556 |
Premium* |
|
Beigene Ltd |
BGNE |
Director, 10% Owner |
2023-11-14 |
20,838 |
2023-11-14 |
9,878,124 |
Premium* |
|
Talis Biomedical Corp |
TLIS |
Director, 10% Owner |
2021-11-18 |
0 |
2021-11-18 |
7,625,425 |
Premium* |
|
Tscan Therapeutics, Inc. |
TCRX |
Director, 10% Owner |
2022-05-10 |
0 |
2022-05-11 |
2,528,583 |
Premium* |
|
DBV Technologies SA |
DBVT |
Director, 10% Owner |
2022-06-13 |
0 |
2022-06-13 |
29,190,248 |
Premium* |
|
Kiniksa Pharmaceuticals, Ltd. |
KNSA |
Director |
2023-06-06 |
29,680 |
2023-06-06 |
2,719,343 |
Premium* |
|
Igm Biosciences, Inc. |
IGMS |
Director |
2023-06-30 |
0 |
2023-09-29 |
2,896,968 |
Premium* |
|
Madrigal Pharmaceuticals Inc |
MDGL |
Director |
2023-11-14 |
0 |
2023-12-14 |
1,793,403 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
114 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 3 of 5
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
SGEN |
Seagen Inc |
Director |
|
2016-03-07 |
4 |
B |
$33.68 |
$2,063,918 |
I/I |
61,265 |
36,682,540 |
2.25 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2016-03-08 |
4 |
OE |
$4.18 |
$83,600 |
I/I |
20,000 |
36,692,540 |
0 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2016-03-08 |
4 |
B |
$0.00 |
$0 |
I/I |
153,200 |
36,830,268 |
2.17 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2016-03-09 |
4 |
B |
$31.15 |
$6,683,985 |
I/I |
208,670 |
37,017,863 |
2.25 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2016-03-10 |
4 |
B |
$32.30 |
$9,386,567 |
I/I |
290,231 |
37,278,782 |
2.25 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2016-03-11 |
4 |
B |
$32.34 |
$6,480,738 |
I/I |
195,765 |
37,454,776 |
2.25 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2016-03-14 |
4 |
B |
$33.77 |
$4,016,519 |
I/I |
118,941 |
37,562,036 |
2.25 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2016-03-15 |
4 |
B |
$31.50 |
$21,210,834 |
I/I |
661,093 |
38,158,204 |
2.25 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2016-03-16 |
4 |
B |
$31.50 |
$18,084,600 |
I/I |
569,203 |
38,671,506 |
2.25 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2016-03-17 |
4 |
B |
$31.73 |
$3,951,304 |
I/I |
124,065 |
38,783,387 |
2.25 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2016-05-20 |
4 |
A |
$38.82 |
$287,268 |
I/I |
7,400 |
38,787,087 |
0 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2016-09-06 |
4 |
B |
$44.98 |
$6,580,527 |
I/I |
143,363 |
4,643,343 |
2.25 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2016-09-07 |
4 |
B |
$47.27 |
$2,889,689 |
I/I |
59,560 |
38,840,624 |
2.25 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2016-09-08 |
4 |
B |
$49.18 |
$10,579,529 |
I/I |
211,093 |
39,030,368 |
2.25 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2016-09-09 |
4 |
B |
$50.33 |
$12,917,842 |
I/I |
256,220 |
39,260,675 |
2.25 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2016-09-12 |
4 |
B |
$49.84 |
$2,551,111 |
I/I |
49,889 |
39,305,533 |
2.25 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2016-09-13 |
4 |
B |
$50.00 |
$7,213,981 |
I/I |
141,202 |
39,432,496 |
2.25 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2016-11-01 |
4 |
B |
$51.83 |
$10,057,349 |
I/I |
184,674 |
39,598,943 |
2.25 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2016-11-02 |
4 |
B |
$55.84 |
$26,200,958 |
I/I |
466,619 |
40,019,506 |
2.25 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2016-11-03 |
4 |
B |
$56.55 |
$21,586,884 |
I/I |
379,336 |
40,361,400 |
2.25 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2016-11-03 |
4 |
B |
$55.99 |
$11,196,763 |
I/I |
198,433 |
40,540,247 |
2.25 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2016-11-07 |
4 |
B |
$58.74 |
$3,301,345 |
I/I |
56,200 |
40,590,914 |
2.25 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2016-11-08 |
4 |
B |
$59.46 |
$19,403,299 |
I/I |
326,300 |
40,885,092 |
2.25 |
- |
|
INCY |
Incyte Corp |
Director |
|
2016-12-30 |
4 |
A |
$100.27 |
$56,853 |
I/I |
567 |
533,909 |
0 |
- |
|
INCY |
Incyte Corp |
Director |
|
2017-03-31 |
4 |
A |
$133.67 |
$56,943 |
I/I |
426 |
767,237 |
0 |
- |
|
114 Records found
|
|
Page 3 of 5 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|